Editorial: The future of inflammatory bowel disease is integration

Bram Verstockt, Virginia Solitano

Open source

DOI
10.1016/j.coph.2026.102667
Published
2026-12
Container
Current Opinion in Pharmacology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.coph.2026.102667,
  title = {Editorial: The future of inflammatory bowel disease is integration},
  author = {Bram Verstockt and Virginia Solitano},
  year = {2026},
  journal = {Current Opinion in Pharmacology},
  doi = {10.1016/j.coph.2026.102667},
  url = {https://doi.org/10.1016/j.coph.2026.102667}
}

RIS

TY  - JOUR
TI  - Editorial: The future of inflammatory bowel disease is integration
AU  - Bram Verstockt
AU  - Virginia Solitano
PY  - 2026
JO  - Current Opinion in Pharmacology
DO  - 10.1016/j.coph.2026.102667
UR  - https://doi.org/10.1016/j.coph.2026.102667
ER  - 

APA

Verstockt, B., & Solitano, V. (2026). Editorial: The future of inflammatory bowel disease is integration. Current Opinion in Pharmacology. https://doi.org/10.1016/j.coph.2026.102667

Source records